Ravindra Attur Prabhu (Ravindra Prabhu Attur, Ravindra Prabhu, Ravindra Prabhu A)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Angiotensin Converting Enzyme

Quality Improvement

Top Venues

International urology and nephrology

Nephrology (Carlton, Vic.)

Global health, epidemiology and genomics

This page only lists publications with an associated author ORCID identifier.

Publications

Leena Sequira, Ravindra Attur Prabhu, Shreemathi S Mayya, Shankar Prasad Nagaraju, Baby S Nayak
Effectiveness of a Disease Management Program (DMP) in controlling the progression of Chronic Kidney Disease among hypertensives and diabetics. F1000Research 11 (2024)
Leena Sequira, Ravindra Attur Prabhu, Shreemathi S Mayya, Shankar Prasad Nagaraju, Baby S Nayak
Effectiveness of a Disease Management Program (DMP) in controlling the progression of Chronic Kidney Disease among hypertensives and diabetics. F1000Research 11 (2024)
Leena Sequira, Ravindra Attur Prabhu, Shreemathi S Mayya, Shankar Prasad Nagaraju, Baby S Nayak
Effectiveness of a Disease Management Program (DMP) in controlling the progression of Chronic Kidney Disease among hypertensives and diabetics. F1000Research 11 (2024)
Brayal D'Souza, Ravindra Attur Prabhu, Bhaskaran Unnikrishnan, Sudarshan Ballal, Suneel C Mundkur, Varalakshmi Chandra Sekaran, Avinash Shetty, Joaquim Paulo Moreira
Effect of Educational Intervention on Knowledge and Level of Adherence among Hemodialysis Patients: A Randomized Controlled Trial. Global health, epidemiology and genomics 2023 (2023)
Bharathi Naik, Pankaj Singhai, Anuja Damani, Ravindra Attur Prabhu, Naveen Salins, Prathvi Naik, Ajith M Nayak, Shankar Prasad Nagaraju
Development and validation of a questionnaire to explore preferences of patients, family caregivers, and kidney care providers on advance care planning in an end-stage kidney disease setting. Palliative & supportive care (2023)
Srinivas Vinayak Shenoy, Indu Ramachandra Rao, Ravindra Attur Prabhu, Shankar Prasad Nagaraju, Ganesh Paramasivam, Dharshan Rangaswamy, Mohan Varadanayakanahalli Bhojaraja, Kiran Krishne Gowda, Mahesha Vankalakunti
Crescentic glomerulonephritis due to coexistent IgA nephropathy and anti-glomerular basement membrane disease in a patient with COVID-19 disease: A case report. Nephrology (Carlton, Vic.) 27 (8) (2022)
Ravindra Attur Prabhu, Srinivas Vinayak Shenoy, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Indu Ramachandra Rao, Mohan V Bhojaraja, Deepak Nayak M, Sindhura Lakshmi Koulmane Laxminarayana, Karan Saraf, Ashok Ramaswamy
Acute Kidney Injury and Progressive Diabetic Kidney Disease: An Epidemiological Perspective. International journal of nephrology and renovascular disease 14 (2021)
Siddharth Venkat Ramanan, Ravindra Attur Prabhu, Indu Ramachandra Rao, Arun Chawla, Srinivas Vinayak Shenoy, Shankar Prasad Nagaraju, Mohan V Bhojaraja
Outcomes and predictors of failure of arteriovenous fistulae for hemodialysis. International urology and nephrology (2021)
Ravindra Attur Prabhu, Tushar Shaw, Indu Ramachandra Rao, Vandana Kalwaje Eshwara, Shankar Prasad Nagaraju, Srinivas Vinayak Shenoy, Chiranjay Mukhopadhyay
Acute kidney injury and its outcomes in melioidosis. Journal of nephrology 34 (6) (2021)
Srinivas Vinayak Shenoy, Shankar Prasad Nagaraju, Mohan Varadanayakanahalli Bhojaraja, Ravindra Attur Prabhu, Dharshan Rangaswamy, Indu Ramachandra Rao
Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade. Nephrology (Carlton, Vic.) 26 (11) (2021)
Ravindra Attur Prabhu, Aswani Srinivas Mareddy, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Vasudeva Guddattu
Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant? International urology and nephrology 51 (7) (2019)